
Artfix Ltd. is a medical device company focused on the field of electrophysiology.
ArtFix aims to deliver a true breakthrough in the atrial fibrillation (AF) market with its innovative one-shot cryoablation catheter.
The key advantages of the ArtFix system include:
- Safety: A controlled cryoablation system minimizes complication rates compared to other ablation methods.
- Efficacy: The cooling tip is designed to create a continuous line with full tissue contact, enabling effective transmural ablations.
- Usability: Offers a genuine “one-shot” procedure, eliminating the need for a 3D mapping system.
The ArtFix system supports both box and linear lesions, making it suitable for treating paroxysmal and persistent AF patients.